Understand the source comparison
Thymalin for Immune System Optimization: Comparison Table
Before the table: Thymalin occupies a distinct niche among immune peptides. It targets thymic restoration rather than direct pathogen response or inflammation modulation. The comparison below clarifies where it fits relative to adjacent peptide categories. Thy
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Before the table: Thymalin occupies a distinct niche among immune peptides. It targets thymic restoration rather than direct pathogen response or inflammation modulation. The comparison below clarifies where it fits relative to adjacent peptide categories.
- Thymalin
- Thymic epithelial activation; restores T-cell differentiation signaling
- Thymic epithelial cells, thymocytes
- Moderate (multiple Russian RCTs, limited Western replication)
- 10mg IM daily × 10 days, cycled every 3–6 months
- Best choice for age-related immune senescence. Targets the upstream organ responsible for T-cell education
- Thymosin Alpha-1 (TA1)
- Direct T-cell activation; enhances Th1 cytokine production
- Mature T-cells, dendritic cells
- High (FDA-approved in multiple countries, extensive oncology data)
- 1.6mg SubQ 2x weekly, ongoing
- Superior for acute viral infections and cancer immunotherapy. Acts on mature immune cells, not thymic restoration
- LL-37 (Cathelicidin)
- Antimicrobial peptide; direct pathogen membrane disruption
- Bacterial/viral pathogens, epithelial barriers
- Moderate (preclinical strong, human trials limited)
- Topical or nebulized administration primarily
- Direct antimicrobial. Not immune optimization but pathogen clearance
- BPC-157
- Tissue repair signaling; indirect immune modulation via growth factor pathways
- Fibroblasts, endothelial cells, gut epithelium
- Low (rodent studies robust, human RCTs absent)
- 250–500mcg SubQ or oral daily
- Wound healing focus. Immune benefits are secondary to tissue regeneration
- Epithalon
- Telomerase activation; affects immune aging indirectly through cellular senescence
- All cell types (non-specific)
- Low (single research group, no independent replication)
- 5–10mg SubQ daily × 10 days, annual cycles
- Speculative longevity tool. Immune effects unproven in isolation